tiprankstipranks
Bio Green Med Solution (BGMS)
NASDAQ:BGMS
US Market
BGMS
Bio Green Med Solution
RESEARCH TOOLSreports

Bio Green Med Solution (BGMS) Ratios

807 Followers

Bio Green Med Solution Ratios

BGMS's free cash flow for Q4 2025 was $0.18. For the 2025 fiscal year, BGMS's free cash flow was decreased by $ and operating cash flow was $-1.62. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.70 4.70 0.59 0.91 3.25
Quick Ratio
 3.66 3.66 0.59 0.91 3.25
Cash Ratio
 2.63 2.63 0.50 0.41 2.44
Solvency Ratio
 -2.23 -2.23 -1.79 -2.75 -2.78
Operating Cash Flow Ratio
 -3.58 -3.58 -1.27 -1.97 -2.77
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 4.91M$ 4.91M$ -2.59M$ -754.00K$ 16.79M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 0.00 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 0.00 0.06 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 0.00 0.06 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.20 1.20 -1.88 14.51 1.37
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 <0.01 <0.01 0.00 10.44 33.91
Net Debt to EBITDA
 0.42 0.42 0.26 0.13 0.66
Profitability Margins
Gross Profit Margin
18.34%18.47%100.00%100.00%0.00%
EBIT Margin
-1127.98%-1128.11%-27916.28%-6060.24%0.00%
EBITDA Margin
-1127.11%-1127.44%-27902.33%-6052.86%0.00%
Operating Profit Margin
-1128.11%-1128.11%-27916.28%-6060.24%0.00%
Pretax Profit Margin
-400.40%-400.40%-27893.02%-6083.57%0.00%
Net Profit Margin
-401.34%-401.34%-26074.42%-5370.24%0.00%
Continuous Operations Profit Margin
-401.34%-401.34%-26074.42%-5370.24%0.00%
Net Income Per EBT
100.23%100.23%93.48%88.27%81.80%
EBT Per EBIT
35.49%35.49%99.92%100.39%93.70%
Return on Assets (ROA)
-36.63%-36.63%-273.86%-256.16%-75.57%
Return on Equity (ROE)
-58.13%-43.82%515.73%-3715.82%-103.74%
Return on Capital Employed (ROCE)
-122.97%-122.97%552.16%-3952.33%-134.65%
Return on Invested Capital (ROIC)
-122.97%-122.97%515.92%-3488.90%-110.14%
Return on Tangible Assets
-45.32%-45.32%-273.86%-256.16%-75.57%
Earnings Yield
-64.52%-92.71%-8346.59%-105689.08%-112644.35%
Efficiency Ratios
Receivables Turnover
 0.59 0.59 0.18 0.11 0.00
Payables Turnover
 0.99 0.99 0.00 0.00 0.01
Inventory Turnover
 0.44 0.44 0.00 0.00 0.00
Fixed Asset Turnover
 5.01 5.01 6.14 4.12 0.00
Asset Turnover
 0.09 0.09 0.01 0.05 0.00
Working Capital Turnover Ratio
 0.14 0.64 -0.03 0.05 0.00
Cash Conversion Cycle
 1.07K 1.07K 2.01K 3.24K -29.21K
Days of Sales Outstanding
 614.20 614.20 2.01K 3.24K 0.00
Days of Inventory Outstanding
 828.13 829.49 0.00 0.00 0.00
Days of Payables Outstanding
 369.19 369.79 0.00 0.00 29.21K
Operating Cycle
 1.44K 1.44K 2.01K 3.24K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -1.04 -2.18 -358.07 -4.54K -6.66K
Free Cash Flow Per Share
 -1.04 -2.18 -358.07 -4.55K -6.66K
CapEx Per Share
 0.00 0.00 0.00 1.69 2.24
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -78.20 -78.20 0.00 -77.84 -100.13
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 -2.69K -2.98K
Operating Cash Flow Coverage Ratio
 -2.38K -2.38K 0.00 -435.46 -196.48
Operating Cash Flow to Sales Ratio
 -6.39 -6.39 -185.81 -38.36 0.00
Free Cash Flow Yield
-216.50%-147.50%-5948.03%-75526.34%-110710.09%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.55 -1.08 -0.01 >-0.01 >-0.01
Price-to-Sales (P/S) Ratio
 2.95 4.33 3.12 0.05 0.00
Price-to-Book (P/B) Ratio
 0.68 0.47 -0.06 0.04 <0.01
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.46 -0.68 -0.02 >-0.01 >-0.01
Price-to-Operating Cash Flow Ratio
 -0.97 -0.68 -0.02 >-0.01 >-0.01
Price-to-Earnings Growth (PEG) Ratio
 -0.02 0.01 <0.01 <0.01 <0.01
Price-to-Fair Value
 0.68 0.47 -0.06 0.04 <0.01
Enterprise Value Multiple
 0.15 0.03 0.25 0.13 0.66
Enterprise Value
 -1.30M -269.09K -3.00M -3.32M -18.22M
EV to EBITDA
 0.15 0.03 0.25 0.13 0.66
EV to Sales
 -1.74 -0.36 -69.83 -7.90 0.00
EV to Free Cash Flow
 0.27 0.06 0.38 0.21 0.87
EV to Operating Cash Flow
 0.27 0.06 0.38 0.21 0.87
Tangible Book Value Per Share
 1.14 2.41 -97.43 171.23 6.54K
Shareholders’ Equity Per Share
 1.49 3.13 -97.43 171.23 6.54K
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 0.07 0.12 0.18
Revenue Per Share
 0.16 0.34 1.93 118.48 0.00
Net Income Per Share
 -0.65 -1.37 -502.46 -6.36K -6.78K
Tax Burden
 1.00 1.00 0.93 0.88 0.82
Interest Burden
 0.35 0.35 1.00 1.00 0.94
Research & Development to Revenue
 1.13 1.14 154.77 45.61 0.00
SG&A to Revenue
 10.33 10.33 125.40 16.00 0.00
Stock-Based Compensation to Revenue
 3.12 3.12 13.77 3.51 0.00
Income Quality
 1.59 1.59 0.71 0.71 0.98
Currency in USD